Frequency of Hyperuricemia in Hypertensive Patients Presenting to Ayub Teaching Hospital
DOI:
https://doi.org/10.70749/ijbr.v3i5.2762Keywords:
Hyperuricemia, Hypertension, Risk factors, Cardiovascular RiskAbstract
Background: Hyperuricemia is increasingly recognized as a common comorbidity in patients with hypertension and a potential contributor to cardiovascular risk. This study aimed to determine the prevalence of hyperuricemia among hypertensive patients presenting to a tertiary care hospital and to identify associated demographic and clinical factors. Methods: A cross-sectional study was conducted on 176 hypertensive patients attending Ayub Teaching Hospital, Abbottabad from September 2024 to February 2025. Hyperuricemia was defined as serum uric acid >7 mg/dL in males or >6 mg/dL in females. Data on demographics, clinical characteristics, and relevant factors (including gender, age, obesity, diabetes, dyslipidemia, alcohol consumption, diuretic use, chronic kidney disease, smoking, hypertriglyceridemia, and central obesity) were collected. Associations were analyzed using Chi-square tests of independence. Results: The prevalence of hyperuricemia in hypertensive patients was 61.4% (108/176 patients) in our study. Hyperuricemia showed significant associations with male gender, older age (≥60 years, obesity (BMI ≥30 kg/m²; diuretic use, chronic kidney disease, smoking, hypertriglyceridemia, and central obesity. No significant associations were found with diabetes, overall dyslipidemia, beta-blocker use, or ACE inhibitor/ARB use. Conclusion: Hyperuricemia is highly prevalent in hypertensive patients in tertiary care settings, with strong links to male gender, advanced age, obesity-related factors, renal impairment, smoking, and diuretic therapy. These findings highlight the need for routine uric acid screening in high-risk hypertensive subgroups to facilitate early intervention and mitigate associated cardiovascular complications.
Downloads
References
1. Stevens G, Mascarenhas M, Mathers C. Global health risks: progress and challenges. Bull World Health Organ. 2009;87(9):646.
https://doi.org/10.2471/blt.09.070565
2. Singh SK, Singh R, Singh SK, Iquebal MA, Jaiswal S, Singh A. Prevalence of Hyperuricemia and the Relationship Between Serum Uric Acid and Hypertension in New Onset Diabetic Patients: A Cross-Sectional Indian Study. Diabetes Metab Syndr Obes. 2022 14;15:1809-17.
https://doi.org/10.2147/DMSO.S363311.
3. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum. 2011 Oct;63(10):3136-41.
https://doi.org/10.1002/art.30520.
4. Liu J, Wang K, Liu H, Zhao H, Zhao X, Lan Y, Huang W, Wang H. Relationship between carotid-femoral pulse wave velocity and uric acid in subjects with hypertension and hyperuricemia. Endocr J. 2019 Jul 28;66(7):629-636.
https://doi.org/10.1507/endocrj.EJ18-0570.
5. Alper AB Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension. 2005 Jan;45(1):34-8.
https://doi.org/10.1161/01.HYP.0000150783.79172.bb.
6. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, Weiss ST, Litonjua AA. Uric acid and the development of hypertension: the normative aging study. Hypertension. 2006 Dec;48(6):1031-6.
https://doi.org/10.1161/01.HYP.0000248752.08807.4c.
7. Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005 Jan;45(1):28-33.
https://doi.org/10.1161/01.HYP.0000150784.92944.9a.
8. Cicero AF, Salvi P, D'Addato S, Rosticci M, Borghi C; Brisighella Heart Study group. Association between serum uric acid, hypertension, vascular stiffness and subclinical atherosclerosis: data from the Brisighella Heart Study. J Hypertens. 2014 Jan;32(1):57-64.
https://doi.org/10.1097/HJH.0b013e328365b916.
9. Feig DI, Johnson RJ. Hyperuricemia in childhood primary hypertension. Hypertension. 2003 Sep;42(3):247-52.
https://doi.org/10.1161/01.HYP.0000085858.66548.59.
10. Poudel B, Yadav BK, Kumar A, Jha B, Raut KB. Serum uric acid level in newly diagnosed essential hypertension in a Nepalese population: a hospital based cross sectional study. Asian Pac J Trop Biomed. 2014 Jan;4(1):59-64.
https://doi.org/10.1016/S2221-1691(14)60209-4.
11. Oumar BH, Ichaka M, Kéita MA, Adama D, Bella DI, Souleymane C, et al. Prevalence of Hyperuricemia (HU) in Arterial Hypertension. Science. 2015;4(4):76-9.
https://doi.org/10.11648/j.sjcm.20150404.12
12. Bocha Y, Jafri A, Agha F, Najam U, Ahmed SZ, Mohyuddin S, et al. Age and Gender Specific Associations between Hyperuricemia and Hypertension: A Cross-Sectional Study in Karachi. Pak J Health Sci. 2025;6(6):165–70.
13. Ahad A, Qadir S, Khan S, Khan T, Khan S, Khalid F. Prevalence and Correlates of Hyperuricemia in Patients with Hypertension: A Cross-Sectional Study from a Tertiary Care Hospital in Pakistan. Pak J Health Sci. 2025;6(2):15–19
https://doi.org/10.54393/pjhs.v6i2.2116
14. Haq E, Hameed A, Riaz G, et al. Frequency of Hyperuricemia in Hypertensive Patients: A Descriptive Cross-Sectional Study at Karachi. Med Forum Mon. 2023;34(7).
15. Siddiqui N, Kumari S, Devi K, et al. Correlating Uric Acid Levels with Hypertension: Insights from a Tertiary Care Hospital. J Pop Ther Clin Pharmacol. 2024.
https://doi.org/10.53555/jptcp.v31i4.5287
16. Yin Y, Zhou E, Wu J. Association between hyperuricemia and long-term mortality in patients with hypertension: results from the NHANES 2001-2018. Front Cardiovasc Med. 2024 Feb 6;11:1306026.
https://doi.org/10.3389/fcvm.2024.1306026.
17. Ram Kumar Mehta, Puru Koirala, Ram L. Mallick, Surya Parajuli, Rajneesh Jha. Prevalence of Hyperuricemia and its Association with Sociodemography among Hypertensive Paents at Birat Medical College Teaching Hospital. BJHS 2021;6(1)14. 1388 - 1391.
https://doi.org/10.3126/bjhs.v6i1.37643
18. Kuwabara M, Ae R, Kosami K, Kanbay M, Andres-Hernando A, Hisatome I, Lanaspa MA. Current updates and future perspectives in uric acid research, 2024. Hypertens Res. 2025 Feb;48(2):867-873.
https://doi.org/10.1038/s41440-024-02031-9.
19. Zheng L, Zhu Y, Ma Y, Zhang H, Zhao H, Zhang Y, Yang Z, Liu Y. Relationship between hyperuricemia and the risk of cardiovascular events and chronic kidney disease in both the general population and hypertensive patients: A systematic review and meta-analysis. Int J Cardiol. 2024 Mar 15;399:131779.
https://doi.org/10.1016/j.ijcard.2024.131779.
20. Shahzad Virk MK, Yaqoob M, Hanif A. Prevalence of Hyperuricemia Among T2DM Patients in Pakistan: A Meta-Analysis. J Health Wellness Community Res. 2025;3(8):e570.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
